Syra Health Corp. Class A Common StockSYRANASDAQ
Loading
R&D Expense Growth TrendStable
Percentile Rank100
Year-over-Year Change
Year-over-year research & development expense growth
Latest
143.76%
↑ 400% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthStable
Average
28.75%
Historical baseline
| Period | Value |
|---|---|
| 2024 | 143.76% |
| 2023 | 0.00% |
| 2022 | 0.00% |
| 2021 | 0.00% |
| 2020 | 0.00% |